Turnover
The micro format states no turnover.
The micro format states no turnover.
Of this, €93,731 falls due within a year.
Lower solvency than 80% of companies in wholesale trade. Sector median 40.5% · 15,469 companies.
In July 2024, 280 companies had the same profile as Labman has now. Each dot is one company, two years later.
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 280 companies, not a prediction for Labman. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| Labman Torhout | €102,667 | €3,597 | 0.1% | - |
| ROGGEN APO Dilbeek | €68,518 | €6,523 | 24.9% | - |
| NOVALAB Uccle | €113,734 | -€4,075 | 0.8% | - |
| Smartvalue Distribution Liège | €56,516 | €8,039 | 38.8% | - |
| DOCA-PHARMA Sint-Niklaas | €72,384 | -€27,380 | -110.2% | - |
| CERDAK Lanaken | €103,436 | -€45,265 | -46.9% | - |
| Medicode Antwerp | €63,460 | -€8,402 | 57.2% | - |
These companies have the same main activity as Labman: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €56,500 and €114,000, founded between 2024 and 2025.
Labman has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €123 and a net result of -€1,877.
Its solvency ranks better than 20% of 15,469 sector peers (NACE 46) in financial year 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.